Full course description
Three Hepatitis C medications were in the Top 10 Medications reimbursed by PharmaCare in 2016/17.
This program will provide practical information on how to manage patients with chronic hepatitis C receiving Direct Acting Antiviral (DAA) regimens. Topics will include patient screening, therapy selection/optimization, common drug-drug interactions, medication coverage, and mini case vignettes.
Program: Hepatitis C Update: How To Manage HCV Therapy With The Next Generation Direct Acting Antivirals
Presenter: Trana Hussaini, BSc(Pharm), PharmD, ACPR, RPh
# of CEUs: 1.5 (BC-2019-009-ISP)
On the learner transcript, the number of credits is equivalent to the number of CEUs.